These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18424113)

  • 1. The implicit rules of evidence-based drug policy: a U.S. perspective.
    MacCoun R; Reuter P
    Int J Drug Policy; 2008 Jun; 19(3):231-2; discussion 233-4. PubMed ID: 18424113
    [No Abstract]   [Full Text] [Related]  

  • 2. Going soft on evidence and due process: Canada adopts US style harm maximization.
    Wodak A
    Int J Drug Policy; 2008 Jun; 19(3):226-8; discussion 233-4. PubMed ID: 18424112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrift from the moorings of good public policy: ignoring evidence and human rights.
    Elliott R
    Int J Drug Policy; 2008 Jun; 19(3):229-30; discussion 233-4. PubMed ID: 18424110
    [No Abstract]   [Full Text] [Related]  

  • 4. The place of supervised injecting facilities within harm reduction: evidence, ethics and policy.
    Fry CL; Cvetkovski S; Cameron J
    Addiction; 2006 Apr; 101(4):465-7. PubMed ID: 16548922
    [No Abstract]   [Full Text] [Related]  

  • 5. Compulsory detoxification is a major challenge to harm reduction in China.
    Larney S; Dolan K
    Int J Drug Policy; 2010 May; 21(3):165-6. PubMed ID: 19505815
    [No Abstract]   [Full Text] [Related]  

  • 6. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 7. Political and legal institutions and their influence on drug policy: an Australian perspective.
    Ryder D
    Drug Alcohol Rev; 2008 Jul; 27(4):374-9. PubMed ID: 18584386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 9. Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.
    Hathaway AD; Tousaw KI
    Int J Drug Policy; 2008 Feb; 19(1):11-6. PubMed ID: 18164610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 11. Reducing the harm of "harm reduction".
    Beirness DJ; Notarandrea R; Jesseman R; Perron M
    Clin Pharmacol Ther; 2008 Apr; 83(4):523-5. PubMed ID: 18349874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canada's new federal 'National Anti-Drug Strategy': an informal audit of reported funding allocation.
    Debeck K; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2009 Mar; 20(2):188-91. PubMed ID: 18571396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug policy, politics, and the law.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2009; 23(1):2-3. PubMed ID: 19296350
    [No Abstract]   [Full Text] [Related]  

  • 14. Practitioners' attitudes concerning evidence-based guidelines in Belgian substance abuse treatment.
    Autrique M; Vanderplasschen W; Broekaert E; Sabbe B
    Eur Addict Res; 2009; 15(1):47-55. PubMed ID: 19052462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attendance at supervised injecting facilities and use of detoxification services.
    Wood E; Tyndall MW; Zhang R; Stoltz JA; Lai C; Montaner JS; Kerr T
    N Engl J Med; 2006 Jun; 354(23):2512-4. PubMed ID: 16760459
    [No Abstract]   [Full Text] [Related]  

  • 17. Supervised injecting facilities: how much evidence is enough?
    Maher L; Salmon A
    Drug Alcohol Rev; 2007 Jul; 26(4):351-3. PubMed ID: 17564869
    [No Abstract]   [Full Text] [Related]  

  • 18. Bringing sex and gender into women's substance use treatment programs.
    Greaves L; Poole N
    Subst Use Misuse; 2008 Jul; 43(8-9):1271-3. PubMed ID: 18649246
    [No Abstract]   [Full Text] [Related]  

  • 19. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    Int J Drug Policy; 2008 Jun; 19(3):220-5. PubMed ID: 18551754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The form and context of federalism: meanings for health care financing.
    France G
    J Health Polit Policy Law; 2008 Aug; 33(4):649-705. PubMed ID: 18617671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.